958 CMR, § 12.01
Current through Register 1538, January 3, 2025
958 CMR 12.00 governs the Commission's review of a Referred Manufacturer's pricing practices pursuant to M.G.L. c. 6D, § 8A and M.G.L. c. 118E, § 12A. 958 CMR 12.00 specifies the procedures by which the Commission may review information relative to a Referred Manufacturer's pricing practices and determine whether its pricing of a Drug is unreasonable or excessive in relation to the Drug's value.
958 CMR, § 12.01